Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FPRG5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,326
Award facts
- Contract value 100% obligated
- $33,326.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $33,326.40 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The contract, awarded on August 29, 2025, with completion targeted for September 22, 2025, represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. This IDC, valued at $499,999,999 and valid through November 2026, serves as the procurement vehicle enabling the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facility needs nationwide and globally.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has established itself as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription medications, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities. This delivery order required no set-aside designation, demonstrating the contractor's competitive positioning in open federal procurement markets. The award reflects the company's consistent capability to provide specialized pharmaceutical products, including contraceptive devices and other medical supplies, to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FPRG5?
SPE2DB25FPRG5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FPRG5 worth?
The government has obligated $33,326 on SPE2DB25FPRG5.
Is contract SPE2DB25FPRG5 an order under another contract?
Yes. SPE2DB25FPRG5 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRG5 competed?
The extent of competition for SPE2DB25FPRG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award